How to Get Filsuvez (Birch Triterpenes Topical Gel) Covered by Cigna in Ohio: Complete Prior Authorization and Appeals Guide
Answer Box: Getting Filsuvez Covered by Cigna in Ohio
Cigna requires prior authorization for Filsuvez (birch triterpenes topical gel) for epidermolysis bullosa patients aged 6+ months with dystrophic or junctional EB subtypes. Submit PA through Express Scripts/Accredo with genetic testing, wound photos, and medical necessity letter. If denied, file internal appeal within 180 days, then external review through Ohio Department of Insurance within 4 months. Start today: Call Cigna member services to confirm specialty pharmacy requirements and download current PA forms.
Table of Contents
- What This Guide Covers
- Before You Start: Verify Your Coverage
- Gather Required Documentation
- Submit Your Prior Authorization Request
- Follow-Up and Timeline Expectations
- If You're Asked for More Information
- If Your Request is Denied
- Appeals Process in Ohio
- Renewal and Re-Authorization
- Quick Reference Checklist
- Frequently Asked Questions
What This Guide Covers
This guide helps Ohio patients with epidermolysis bullosa (EB) and their healthcare teams navigate Cigna's prior authorization process for Filsuvez (birch triterpenes topical gel). We'll walk through the exact forms, documentation requirements, and appeal procedures specific to Ohio residents with Cigna coverage.
Who this helps: Patients with junctional or dystrophic EB, their caregivers, dermatologists, wound care specialists, and patient advocates working to secure coverage for this FDA-approved topical therapy.
Before You Start: Verify Your Coverage
Step 1: Confirm Your Plan Type and Pharmacy Benefit
Call the member services number on your Cigna ID card and ask:
- "Is Filsuvez covered under my pharmacy or medical benefit?"
- "What specialty pharmacy must I use?" (typically Accredo for Cigna)
- "What's my copay or coinsurance for specialty tier medications?"
Coverage at a Glance
| Requirement | Details | Where to Find It |
|---|---|---|
| Prior Authorization | Required for all plans | Cigna PA Policy CNF-850 |
| Formulary Tier | Specialty Tier 5 (typically) | Plan-specific formulary |
| Age Requirement | ≥6 months | FDA labeling |
| EB Subtype | Dystrophic or junctional only | Genetic testing required |
| Specialty Pharmacy | Accredo (verify annually) | Member services |
| Wound Criteria | 10-50 cm², 21 days to 9 months old, non-infected | PA policy |
Gather Required Documentation
Essential Documents Checklist
Patient Information:
- Cigna member ID and policy number
- Complete medical history including EB diagnosis date
- ICD-10 code: Q81.1 (junctional EB) or Q81.2 (dystrophic EB)
Clinical Documentation:
- Genetic testing results confirming dystrophic or junctional EB subtype
- Wound assessment with measurements, photos, and infection status
- Medical necessity letter from dermatologist or wound specialist
- Prior treatment records showing failed or inadequate alternatives
- Current wound photos (if accepted by your provider)
Clinician Corner: Your medical necessity letter should address: (1) confirmed EB subtype with genetic evidence, (2) wound characteristics meeting size/age criteria, (3) prior treatments attempted and outcomes, (4) clinical rationale for Filsuvez based on FDA labeling and EB wound care guidelines.
Submit Your Prior Authorization Request
Step-by-Step: Fastest Path to Approval
- Download Current Forms (Patient/Clinic)
- Access Cigna provider portal or call 1-800-88-CIGNA
- Request Filsuvez-specific PA form (Policy CNF-850)
- Timeline: Same day
- Complete Medical Assessment (Prescriber)
- Document wound size (10-50 cm²), age (21 days to 9 months), infection status
- Include genetic testing confirming EB subtype
- Timeline: 1-2 business days
- Submit Complete Package (Clinic)
- Via Cigna provider portal, CoverMyMeds, or fax
- Include all required documentation from checklist above
- Timeline: Same day submission
- Confirm Receipt (Patient/Clinic)
- Call Cigna within 24 hours to verify submission received
- Document reference number and representative name
- Timeline: 24 hours
- Arrange Specialty Pharmacy (Patient)
- Contact Accredo or designated specialty pharmacy
- Provide PA reference number once approved
- Timeline: 2-3 business days after approval
Follow-Up and Timeline Expectations
Ohio-Specific Timelines
Standard Review: 72 hours for urgent cases, up to 30 days for standard cases under federal regulations
When to Call Cigna:
- Day 3: Confirm receipt and review status
- Day 7: Request status update if no decision
- Day 14: Escalate if approaching timeline limits
Sample Follow-Up Script: "Hi, I'm calling about prior authorization request #[reference number] for Filsuvez for my epidermolysis bullosa. Can you provide a status update and expected decision date? If additional information is needed, how can I submit it today?"
If You're Asked for More Information
Common Additional Requests
Missing EB Subtype Confirmation:
- Submit complete genetic panel results
- Include dermatologist's interpretation letter
- Reference specific mutations (e.g., COL7A1 for dystrophic EB)
Wound Criteria Clarification:
- Provide detailed wound measurements with ruler/grid photos
- Document wound age from initial appearance
- Include infection screening results
Prior Treatment Documentation:
- List all previous wound care approaches and outcomes
- Include duration of each treatment and reason for discontinuation
- Reference EB-specific wound care protocols attempted
If Your Request is Denied
Common Denial Reasons & Solutions
| Denial Reason | Solution | Required Documentation |
|---|---|---|
| Missing genetic confirmation | Submit genetic testing | Complete EB genetic panel with interpretation |
| Wound doesn't meet size criteria | Provide detailed measurements | Photos with measuring device, clinical notes |
| Cancer screening incomplete | Rule out malignancy | Biopsy results or clinical assessment |
| Non-formulary status | Request formulary exception | Medical necessity vs. alternatives comparison |
Counterforce Health: Streamlined Appeals Support
Counterforce Health helps patients and clinicians turn insurance denials into targeted, evidence-backed appeals. Their platform analyzes denial letters and drafts point-by-point rebuttals using the right clinical evidence and payer-specific requirements, potentially saving weeks of back-and-forth with insurers.
Appeals Process in Ohio
Internal Appeal with Cigna
Timeline: Must file within 180 days of denial date Decision Time: 30 days for standard, 72 hours for urgent cases
How to File:
- Follow instructions in denial letter
- Submit written appeal with:
- Copy of denial letter
- Updated medical necessity letter
- Additional clinical evidence
- EB treatment guidelines references
Appeal Address: Use address provided in your specific denial letter (varies by plan type)
External Review Through Ohio Department of Insurance
If Cigna upholds the denial after internal appeal:
Eligibility: Medical necessity denials, experimental/investigational determinations Deadline: 4 months (120 days) from Cigna's final internal decision Timeline: 45 days for standard review, 72 hours for expedited
Ohio Department of Insurance Contact:
- Consumer Hotline: 1-800-686-1526
- Email: [email protected]
- Address: Ohio Department of Insurance, Consumer Services Division, 50 W. Town Street, Suite 300, Columbus, OH 43215
Note: Self-funded employer plans follow federal ERISA rules, not Ohio state external review. Check your plan documents or call ODI to confirm which process applies.
Renewal and Re-Authorization
Preparation Timeline
Start 6-8 weeks before expiration for standard renewals Start 10-12 weeks before if clinical status has changed significantly
Required Documentation for Renewal
- Updated medical necessity letter showing continued benefit
- Recent progress notes with wound healing measurements
- Current wound photos (if accepted)
- Documentation of ongoing medical need and safety
Cigna typically approves Filsuvez for 6-12 month periods, with renewal required based on continued wound healing needs and EB management.
Quick Reference Checklist
Before Submitting:
- Confirmed specialty pharmacy requirement (usually Accredo)
- Downloaded current Cigna PA form for Filsuvez
- Genetic testing confirming junctional or dystrophic EB
- Wound assessment meeting all size/age/infection criteria
- Medical necessity letter from specialist
- Prior treatment documentation
After Submission:
- Called within 24 hours to confirm receipt
- Documented PA reference number
- Set calendar reminders for follow-up calls
- Prepared appeal documents in case of denial
If Denied:
- Filed internal appeal within 180 days
- Contacted Ohio Department of Insurance if needed
- Gathered additional clinical evidence
- Considered Counterforce Health assistance
Frequently Asked Questions
Q: How long does Cigna prior authorization take in Ohio? A: Standard cases: up to 30 days. Urgent cases: 72 hours. Most Filsuvez approvals for properly documented EB cases are decided within 3-5 business days.
Q: What if Filsuvez is non-formulary on my plan? A: Request a formulary exception with your PA submission. Include medical necessity documentation showing why alternatives are inadequate for your EB subtype.
Q: Can I request expedited review? A: Yes, if delay would seriously jeopardize your health. Document clinical urgency and request expedited review in your initial submission.
Q: Does step therapy apply if I've tried treatments outside Ohio? A: Prior treatment documentation from any location is typically accepted. Include detailed records of what was tried, duration, and outcomes.
Q: What's my cost sharing for Filsuvez? A: Specialty tier medications typically have coinsurance (often 25-40%) rather than flat copays. Check your plan documents or call member services for exact amounts.
Q: Can my dermatologist handle the PA submission? A: Yes, dermatologists and wound care specialists are the preferred prescribers for Filsuvez PA requests. Include provider NPI and credentials in submission.
From our advocates: We've seen cases where initial Filsuvez denials were overturned simply by submitting complete genetic testing results that clearly confirmed the EB subtype. Don't assume a denial is final—often it's just missing documentation that can be easily provided.
Sources & Further Reading
- Cigna Filsuvez Coverage Policy CNF-850 (PDF)
- Ohio Department of Insurance Consumer Services
- Cigna Prior Authorization Portal
- FDA Filsuvez Prescribing Information
- EB-CLINET International Consensus Guidelines
Disclaimer: This guide provides general information about insurance coverage processes and should not be considered medical or legal advice. Coverage policies and procedures may vary by plan and change over time. Always consult your healthcare provider about treatment decisions and contact your insurance company directly for plan-specific information. For assistance with complex appeals, consider consulting with qualified patient advocates or healthcare coverage specialists.
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.